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A B S T R A C T
Diabetes mellitus type 2 (DMT2) is characterized by hyperglycemia and associated with low grade inﬂammation
aﬀecting both endothelial cells and monocytes. Exosomes are nanovesicles, allow communication between en-
dothelial cells and monocytes and have been associated with diabetic complications. In this study we evaluated
whether high glucose can activate monocytes and endothelial cells and whether exosomes play a role in this
activation. Moreover, we studied whether endothelial cells and monocytes communicate with each other via
exosomes under high and basal glncubation. In the ﬁrst experiment, monomac 6 cells (MM6) were exposed to
high glucose (HG; 25mmol/L) or to exosomes from MM6 exposed to HG (exoMM6-HG) or basal glucose
(5.5 mmol/L) (exoMM6-BG). In the second experiment, MM6 were exposed to exosomes from human umbilical
vein endothelial cells (HUVECs) and HUVECs to exosomes from MM6. In the third experiment, MM6 and
HUVECs were exposed to a mixture of exosomes from MM6 and HUVECs (exoMix). Cell activation was evaluated
by measuring the protein surface expression of intracellular adhesion molecule-1 (ICAM-1) by ﬂow cytometry.
HG increased ICAM-1 expression in MM6 and monocytic exosomes from HG or BG shown similar eﬀect in HG
and BG MM6 cells. Exosomes from HUVECs increased ICAM-1 expression in MM6 cells, incubated under HG or
BG, while also exosomes from MM6 increased ICAM-1 expression in HUVECs incubated under HG or BG. The
combination of exosomes from both cell types (exoMixHG or exoMixBG) also increased ICAM-1 expression in
both type cells in most conditions. However, the exoMixBG reversed the eﬀect of HG in both MM6 and HUVECs.
Our results show that HG activated monocytes and endothelial cells and that exosomes play a role in this HG-
induced cell ICAM-1 expression. We hypothesize that during DMT2, exosomes may act as a communication
mechanism between monocytes and endothelial cells, inducing and maintaining activating of both cell types in
the presence of high glucose.
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1. Introduction
Diabetes is one of the major health burdens in the world. It is es-
timated that 415 millions of adults suﬀer from this disease in 2015
(Ogurtsova et al., 2017). Moreover, the worldwide prevalence is in-
creasing (Riddle et al., 2018). Diabetes mellitus Type 2 (DMT2) is the
most common type of diabetes, since around 90% of all diabetes pa-
tients have type 2 diabetes (Ji et al., 2017). DMT2 is a complex disease,
which is characterized by insulin resistance, beta-cell deﬁciency, re-
sulting in decreased insulin secretion and hyperglycemia (Chénard
et al., 2017). A combination of various factors, such as genetic, lifestyle
(such as diet), environmental factors, is responsible for the develop-
ment of the disease.
DMT2 is viewed as a chronic low-grade inﬂammatory disease, in
which both immune cells and endothelial cells are involved (Kimball
et al., 2017; Raygan et al., 2016). Hallmarks of the low-grade in-
ﬂammatory process are endothelial and monocyte cell activation
(Davison et al., 2017; Halvorsen et al., 2016). This cell activation leads
to the endothelial and monocytes cells to secrete cytokines and express
adhesion molecules such as intracellular adhesion molecule type I
(ICAM-1) (Altannavch et al., 2004; Faas et al., 2010; Sáez et al., 2018;
Štulc et al., 2014), which mediates the adhesion and transmigration of
immune cells into vascular wall. Additionally, patients with DMT2 have
increased circulating levels of ICAM-1 (Karimi et al., 2018), which is a
marker of endothelial cell activation (Schnoor, 2015). Exosomes are
extracellular nanovesicles released by various cell types including en-
dothelial cells and monocytes (de Jong et al., 2012; Tang et al., 2016).
Exosomal cargo includes proteins, mRNAs and microRNAs (Kowal
et al., 2014), which are able to modulate endothelial cell and monocyte
function (Rice et al., 2015). Exosomes have been recognized as com-
munication mechanism(Simons and Raposo, 2009), leading to interac-
tions between diﬀerent cell types, such as endothelial cells and immune
cells (as monocytes) (Müller, 2012) and modulate their cellular func-
tion.
In the present study, we hypothesize that monocytes and en-
dothelial cells produce exosomes in the presence of high glucose and
that the glucose-modulated exosomes activated monocytes and en-
dothelial cells. We used ICAM-1 as a measure of activation of mono-
cytes and endothelial cells. We also studied whether monocyte and
HUVECs can communicate and interact with each other via exosomes
under basal or high glucose conditions.
2. Material and methods
2.1. Cell culture and treatment
The monocyte cell line (monomac-6 (MM6)) was used for the ex-
periments. MM6 cells show phenotypical and functional features of
mature monocytes (Ziegler‐Heitbroc et al., 1988). MM6 were cultured
(250.000 cells/mL) in monocyte culture medium (RPMI 1640 (Lonza,
Basel, Switzerland) supplemented with 2mmol/L L-Glutamine, 100 IE/
mL Penicillin, 100 μg/mL Streptomycin, 10% heat-inactivated fetal calf
serum, at 37 °C and 5% CO2 (Corning® Costar®; Sigma-Aldrich, Zwijn-
drecht, The Netherlands). The MM6 cell line was cultured as described
before (Faas et al., 2010). Cells were used for experiments under basal
(5.5 mmol/L) and high (25mmol/L) levels of glucose.
Human umbilical vein endothelial cells (HUVECs) were provided by
the Endothelial Cell facility of the UMCG (Groningen, Netherlands).
HUVECs were isolated by collagenase digestion (0.25mg/mL
Collagenase Type II from Clostridium histolyticum; Boehringer,
Mannheim, Germany), as previously described (Faas et al., 2010).
HUVECs were cultured in HUVECs culture medium (RPMI (Lonza,
Basel, Switzerland) supplemented with 2mmol/L L-Glutamine, 5 U/mL
Heparin, 100 IE/mL Penicillin, 100 μg/mL Streptomycin, 50 μg/mL
Crude ECGF solution and 20% FCS) at 37 °C, 5% CO2 on gelatin-pre-
coated tissue culture ﬂasks (Corning® Costar®; Sigma-Aldrich,
Zwijndrecht, The Netherlands). Cells were used for experiments under
basal (5.5 mmol/L) and high (25mmol/L) levels of glucose.
Co-culture of HUVECs and MM6: conﬂuent HUVECs in passage 2 in
12 wells-plate were co-cultured with MM6 cells (125.000 cells/mL). 3
days before the start of the co-culture, MM6 cells were transferred to
endothelial cell medium. Cells in co-culture were exposed to high glu-
cose (25mmol/L) or basal glucose (5.5 mmol/L) in exosome-free
medium, during 24 h. After this, the supernatant was collected and
centrifuged at 1200 rpm for 10min at 4 °C, to collect the MM6 cells.
MM6 cells were not attached to endothelial cells. HUVECs were washed
with PBS (3×) and trypsin was used to isolate HUVECs as described
above. HUVECs and MM6 were prepared for ﬂow cytometry. Dead cells
were excluded of the analysis by centrifugation.
2.2. Exosome isolation and puriﬁcation
Before isolation of exosomes, HUVECs and MM6 cells were exposed
to high glucose (HG, 25mmol/L) (HUVEC-HG and MM6-HG) or to basal
glucose (5.5 mmol/L; HUVEC-BG and MM6-BG) during 24 h. Exosomes
were isolated as we previously described (Sáez et al., 2018). Super-
natants (40mL) from MM6 and HUVECs (HG and BG conditions) were
collected after 24 h incubation. Exosomes were isolated and puriﬁed by
diﬀerential ultracentrifugation. In brief, supernatant was ﬁltered
through a 0.22 μm ﬁlter and then, centrifugation was initially per-
formed at 2000 g at 4 °C for 30min, followed by 12,000 g at 4 °C for
45min. Then the supernatant was centrifuged at 110,000 g at 4 °C for
70min (Centrikon T-1080 ultracentrifuge, Kontron Instruments). The
pellet was resuspended in PBS (pH 7.4) and again centrifuged at
110,000 g at 4 °C for 70min. The exosome pellet was resuspended in
sucrose/HEPES 2mmol/L and subsequently puriﬁed using a dis-
continuous sucrose gradient (following the protocol described by Théry
et al (Théry et al., 2006); from 2mmol/L to 0.25mmol/L). Thus, exo-
somes were mixed with 2mL of 2M sucrose in HEPES and placed on the
bottom of a SW41 centrifuge tube, overlaid with 1.5mL 1.35mmol/L
sucrose, 0.5 mL 1.28mmol/L sucrose, 1 mL 1.15mmol/L sucrose and
5mL 0.25mmol/L sucrose, and ultracentrifuged for 16 h at 210,000 g at
4 °C. Thus, based on our previous study (Sáez et al., 2018), we collected
the ﬁrst 11 fractions, since exosomes were only present in fraction 11.
Fractions were collected with 1mL sucrose and refractive index was
measured. After this, all fractions were washed and ultracentrifuged
again with PBS at 110,000 g at 4 °C for 70min. Fraction 11 showed
ﬂoating density for exosomes (1.16 g/mL) and exosomal markers by
western blotting (see results) and was used for the experiments de-
scribed below. The ﬁnal pellet was re-suspended in 300 μL of PBS and
stored at −80 °C for later incubation experiments with HUVECs. The
exosomal protein concentration was determined using the BSA™ Protein
Assay Kit (Bio-Rad Laboratories, Hercules, CA, USA).
2.3. Preparation of exosomes for TEM
10 μL of exosome suspension was allowed to adhere on freshly
prepared Formvar coated 200 mesh EM grids for 2min. After draining
the liquid with a ﬁlter paper, samples were stained for 1min on a drop
of 2% ammonium molybdate in water. After draining the liquid again
with ﬁlter paper and air-drying for 5min, samples were examined in a
FEI Cm100 transmission electron microscope operated at 80 KV.
Pictures were taken with a Morada camera using Olympus-sis software.
2.4. Nanoparticle tracking analysis
Quantiﬁcation and size distribution of exosomes were determined
using the Nanoparticle Tracking Analysis (NTA) equipped with a
405 nm laser with LM14 module (NanoSight NTA 3.0 Nanoparticle
Tracking, Version 3.0). Samples were diluted with PBS (1/10) prior to
analysis in order to obtain particle distribution of particles per image
(50 particles per image). Samples were measured using capture 60 and
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repeat 3. Settings were kept constant in all samples. Each video was
analyzed to get the mean particle size and the concentration of parti-
cles.
2.5. Western blotting of exosomes
Exosomal pellets isolated from cells exposed to exosomes were lysed
with RIPA buﬀer (1X) (Radio-Immunoprecipitation Assay buﬀer,
25 mmol/L Tris·HCl pH 7.6, 150mmol/L NaCl, 1% NP-40, 1% sodium
deoxycholate, 0.1% SDS) (Pierce®RIPA Buﬀer, Thermo Fisher Scientiﬁc
Inc, Landsmeer, Netherlands) at room temperature for 5min and then
loading buﬀer (5×) was added to the samples and incubated at 95 °C
for 5min. Twenty μg of exosomal protein per well was separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred onto polyvinylidene ﬂuoride (PVDF) membranes
(Immobilon®-FL, Millipore, Amsterdam-Zuidoost, Netherlands).
Membranes were probed with primary antibody, polyclonal rabbit anti-
CD63 (1:200; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA)
After incubation at 4 °C overnight, membranes were washed in Tris
buﬀered saline (pH 7.4) and incubated for 1 h at room temperature with
secondary antibody IRDye® 800CW or 680CW Secondary Antibodies
(LI-COR, Lincoln, Nebraska USA). Membranes were analyzed using LI-
COR Odissey Scanner (LI-COR, Lincoln, Nebraska USA).
2.6. Treatment of MM6 and HUVECs with high and basal glucose
MM6 and HUVECs were exposed to high glucose (HG, 25mmol/L;
MM6-HG or HUVEC-HG) or to basal glucose (5.5 mmol/L; MM6-BG or
HUVEC-BG) for 24 h. Thereafter, cells were exposed to exosomes and
prepared for ﬂow cytometry.
2.7. Experiment 1: treatment of MM6 with exosomes from MM6 treated
with high and basal glucose
To study the role of exosomes in HG-induced MM6 cell activation,
exosomes from MM6-HG (exoMM6-HG) and MM6-BG (exoMM6-BG)
were isolated from the supernatant as described above. MM6-HG and
MM6-BG cells (250.000 cells/mL) were washed and exposed to
exoMM6-BG or exoMM6-HG (concentration of exosomes: 0.5 μg pro-
tein/cm2 (equivalent to ˜2.7× 107 particles per cm2) in exosome-free
medium for another 12 h. Then MM6 cells were washed and prepared
for ﬂow cytometry (Fig. 1A).
2.8. Experiment 2: treatment of MM6 with exosomes from HUVECs and
treatment of HUVECs with exosomes from MM6
2.8.1. Experiment 2a: Exposure of HUVECs to exoMM6
To study whether exosomes from MM6 can inﬂuence HUVECs ac-
tivation, exosomes from MM6 incubated with HG (exoMM6-HG) or BG
(exoMM6-BG) were isolated as described before. Conﬂuent HUVECs in
passage 2 were preincubated in high (25mmol/L) (HUVEC-HG) of basal
(5.5 mmol/L) (HUVEC-BG) glucose medium for 24 h. Then HUVECs
were washed and exposed to exoMM6-BG or exoMM6-HG in exosome-
free medium for another 12 h (exosome concentration: 0.5 μg protein/
cm2, equivalent to ˜2.7× 107 particles per cm2). Then cells were wa-
shed with PBS and prepared for ﬂow cytometry (Fig. 1B).
2.8.2. Experiment 2b: Exposure of MM6 to exoHUVEC
To evaluate the eﬀect of exosomes from HUVECs on MM6 activa-
tion, exosomes from HUVEC-HG (exoHUVEC-HG) and exosomes from
HUVEC-BG (exoHUVEC-BG) were isolated as described before. MM6
cells (250.000 cells/mL) were preincubated with high (25mmol/L) or
basal (5.5 mmol/L) glucose for 24 h, washed and exposed to
exoHUVEC-BG or exoHUVEC-HG for another 12 h in exosome-free
medium (exosome concentration: 0.5 μg protein/cm2, equivalent to
˜2×105 particles per cm2). Finally, cells were washed with PBS and
prepared for ﬂow cytometric analysis (Fig. 1C).
2.9. Experiment 3: Exposure of HUVECs and MM6 to exosomal mix from
MM6 and HUVECs
Conﬂuent HUVECs in passage 2 or MM6 cells (250.000 cells/mL)
were preincubated with high (25mmol/L) or basal (5.5 mmol/L) glu-
cose during 24 h. After this, cells were exposed to a mixture of exoMM6-
BG and exoHUVEC-BG (exoMix-BG) or exoMM6-HG and exoHUVEC-HG
(exoMix-HG) for 12 h, in a 1:1 ratio in the same concentration as de-
scribed above. After incubation, the cells were washed with PBS and
prepared for ﬂow cytometry (Fig. 1D).
For control, conﬂuent HUVECs in passage 2 in 12 wells-plates were
co-cultured with MM6 cells (125.000 cells/mL) as described above and
were exposed to high (25mmol/L) or basal glucose (5.5 mmol/L) in
exosome-free medium, during 24 h as described above. HUVECs and
MM6 were prepared for ﬂow cytometry as described above. These cells
were used as controls for incubation of MM6 or HUVECs with exoMix.
2.10. Flow cytometry analysis
To measure monocyte or HUVECs activation, ICAM-1 expression on
these cells was measured using ﬂow cytometry. Therefore, after dif-
ferent exposures (D-glucose and exosomes), MM6 cells were washed
with PBS, while HUVECs were washed with PBS and trypsinized, in
order to continue with ﬂow cytometer protocol. Then both cell types
were incubated with a solution of PBS-FCS 5% (PBS and Fetal calf
serum 5%) and mouse ﬂuorescein isothiocyanate (FITC) conjugated
anti-ICAM-1 (BioLegend Inc. Uithoorn, The Netherlands). Mouse IgG1 κ
(BioLegend Inc. Uithoorn, The Netherlands) was used as isotype control
to test for non-speciﬁc antibody binding. HUVECs and MM6 cells ex-
posed to LPS (lipopolysaccharide, 2 μg, for 4 h at 37 °C) served as po-
sitive control and on these cells increased ICAM-1 expression was al-
ways induced (data not shown). To measure dead cells (apoptotic cells)
propidium iodide staining (PI) was performed. Flow cytometric analysis
was performed using a BD FACSCalibur with two lasers (488 and
635 nm) (BD Biosciences, Breda, The Netherlands). ICAM-1 expression
in cells was analyzed using Kaluza Flow Cytometry Analysis Software.
HUVECs and MM6 cells were gated based on size and scatter in the
forward-side scatter plot. In a forward scatter-PI plot, live cells were
selected as cells negative for PI. These live cells were copied to a for-
wardscatter-FITC plot. The isotype of each sample was used to set a gate
excluding all positive cells. This gate was copied to the sample stained
for ICAM-1 and percentage positive cells were determined.
2.11. Statistical analysis
All data are expressed as median ± interquartile range. The data
displayed a non-parametric distribution as tested by the Shapiro-Wilk
normality test. Comparisons between groups were performed using
Kruskal Wallis test, followed by Wilcoxon’s signed rank test or Man
Whitney U test where appropriate. P < 0.05 was considered to be
signiﬁcant.
3. Results
3.1. High glucose aﬀects exosomes derived from MM6
Exosomes from MM6 and HUVECs were isolated after exposure to
BG or HG in exosome-free culture medium for 24 h. From each super-
natant, 12 fractions were collected after sucrose gradient isolation,
however, only fractions from 4 to 11 were used to characterize exo-
somes by western blotting using anti-CD63 (following the protocol used
in our previous study Sáez et al., 2018). Exosomes, characterized by
expression of CD63, were only found in fraction 11 of both cell types
(exosomes derived from HUVECs are shown in Sáez et al. (Sáez et al.,
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2018)) (Fig. 2A), so this fraction was used for all subsequent experi-
ments. Fractions 11 were also characterized by electron microscopy and
exosomes were found in all fractions 11 (Fig. 2B). Exosomes from
fractions 11 were analyzed by NTA (Fig. 2C). Although the concentra-
tion of exosomes from MM6-HG appeared to be decreased as compared
with MM6-BG, this was not signiﬁcant (Fig. 2D). The analysis of exo-
somal size showed that HG increased the size of exosomes as compared
to BG in MM6 (205 nm vs 180 nm, respectively) (Fig. 2E).
Fig. 1. Schematic representation of exosome isolation and exposure to MM6 and HUVECs. Exosomes were isolated from the supernatant of MM6 and HUVECs
exposed to basal glucose (BG) and high glucose (HG), after 24 h incubation with exosome-free culture medium. Exosomes from all conditions were puriﬁed and
characterized as described in Fig. 2. A) Experiment 1: MM6-BG and HG were exposed during 12 h with exoMM6-BG or exoMM6-HG. B) Experiment 2a: MM6-BG and
HG were exposed during 12 h with exoHUVEC-BG or exoHUVEC-HG. C) Experiment 2b: HUVEC-BG and HUVEC-HG were exposed during 12 h with exoMM6-BG or
exoMM6-HG. D) Experiment 3: HUVECs or MM6 (BG or HG) were exposed to exoMixBG or exoMixHG (exosomes from monocytes and HUVECs under BG or HG)
during 12 h.
Fig. 2. Exosomes derived from MM6 cells under BG and HG. Exosomes were isolated by the ultracentrifugation protocol. A) After the sucrose gradient isolation,
western blotting for each fraction (fractions 4–11 are shown) collected was performed. Only fraction 11 of MM6 showed expression of the exosomal marker CD63.
Characterization for exosomes derived from HUVECs are shown in previous studies (Sáez et al., 2018). B) Fractions 11 were analyzed by electron microscopy and all
fractions showed exosomes. C) NTA analysis was performed to determine the exosomal concentration and particle size derived from MM6 basal glucose (BG,
5.5 mmol/L, left panel) and high D-glucose (HG, 25mmol/L, right panel). D) and E) Median (with interquartile range) exosomal concentration (D) and exosomal size
(E) for exosomes from MM6 (n=5), * p < 0.05, Wilcoxon signed rank test.
T. Sáez, et al. Immunobiology 224 (2019) 325–333
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3.2. Experiment 1
3.2.1. High glucose and exosomes derived from MM6-BG and MM6-HG
increased the protein surface expression of ICAM-1 in MM6
HG increased the expression of ICAM-1 in MM6 cells as compared to
MM6-BG (Fig. 3A). To evaluate whether exosomes play a role in this
HG-induced monocyte activation, ICAM-1 was analyzed in MM6-BG or
MM6-HG exposed to exoMM6-BG or exoMM6-HG. exoMM6-HG in-
creased ICAM-1 expression in MM6-BG as compared to MM6-BG and
HG (Fig. 3A). In MM6-HG the exposure to exoMM6-BG also increased
the expression of ICAM-1 as compared to MM6-HG and MM6-BG
(Fig. 3A). In MM6-BG exposed to exoMM6-BG and in MM6-HG exposed
to exoMM6-HG, exosomes also increased the expression of ICAM-1
(Fig. 3B).
3.3. Experiment 2a
3.3.1. Exosomes derived from MM6 modulate ICAM-1 protein surface
expression in HUVECs
To evaluate whether monocytes can communicate with HUVECs via
exosomes, we studied the expression of ICAM-1 in HUVECs exposed to
exosomes from MM6. ExoMM6-HG increased the expression of ICAM-1
in HUVEC-BG as compared with HUVEC-BG and HUVEC-HG (Fig. 4A).
ExoMM6-BG also increased the expression of ICAM-1 in HUVEC-BG as
compared with HUVEC-BG (Fig. 4A). The exposure of HUVEC-HG to
exoMM6-BG decreased the expression of ICAM-1 as compared with
HUVEC-HG (Fig. 4A) to the level of ICAM-1 expression in HUVEC-BG.
Exposure of HUVEC-HG to exoMM6-HG highly increased the expression
of ICAM-1 as compared with HUVEC-HG and HUVEC-BG (Fig. 4A).
3.4. Experiment 2b
3.4.1. Exosomes derived from HUVECs modulate ICAM-1 protein surface
expression in MM6
To study whether HUVECs communicate with monocytes by way of
exosomes, MM6-BG and MM6-HG were exposed during 12 h to
exoHUVEC-BG or exoHUVEC-HG. The exposure of MM6-BG cells to
exoHUVEC-HG increased the expression of ICAM-1 as compared with
MM6-BG to similar levels as seen in MM6-HG. Similarly, in MM6-BG
exposed to exoHUVEC-BG ICAM-1 expression was increased as com-
pared with MM6-BG to the level of ICAM-1 expression in MM6-HG
(Fig. 4B). The expression of ICAM-1 was higher after the incubation of
MM6-HG with exoHUVEC-BG as compared with MM6-HG (Fig. 4B). No
diﬀerences were found after the incubation of MM6-HG incubated with
exoHUVEC-HG as compared with MM6-HG (Fig. 4B).
3.5. Experiment 3
3.5.1. A mix of exosomes from monocytes and endothelial cells modulate
the protein surface expression of ICAM-1 in monocytes and in endothelial
cells
To study whether exosomes derived from monocytes and en-
dothelial cells can interact with each other and modulate ICAM-1 ex-
pression in both cell types, we ﬁrst evaluated ICAM-1 expression on
MM6 and HUVECs after co-culture of the cells for 24 h. Thus, MM6 and
HUVECs were co-cultured in presence of BG and HG and ICAM-1 ex-
pression in co-cultured cells was compared to expression of ICAM-1 in
monocultures of MM6 and HUVECs (Fig. 5A and B). HG increased the
expression of ICAM-1 in co-cultured MM6 and HUVECs (Fig. 5A). Also,
in monocultures of MM6 and HUVEC HG increased ICAM-1 expression
as compared to BG. The eﬀect of HG seemed to be stronger in co-
Fig. 3. Eﬀect of high glucose and exosomes on ICAM-1 expression by MM6 exosomes. Percentage of positive cells for ICAM-1 was evaluated in A) MM6-BG and HG
incubated with exosomes from HG (exoMM6-HG) or MM6-BG (exoMM6-BG) (n=5) B) Representative ﬂow cytometric dot plots from each condition. p < 0.05,
Wilcoxon Signed rank test (* vs MM6-BG, + vs MM6-HG).
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cultured cells as compared with monocultures (Fig. 5B), this was sig-
niﬁcant in MM6-HG but not in HUVEC-HG.
The question arose whether this increased ICAM-1 expression in the
co-cultures could be due to a collaboration of exosomes released from
both cell types. To test this, monocultures of HUVECs or MM6 cells
were exposed to a mix of exoMM6-BG and exoHUVEC-BG or exoMM6-
HG and exoHUVEC-HG (exoMix-BG or exoMix-HG, respectively)
(Fig. 5C–F). Expression of ICAM-1 was compared to expression of this
molecule in co-cultured cells. ExoMix-HG increased the expression of
ICAM-1 in MM6-BG (Fig. 5C) and also in HUVEC-BG (Fig. 5E) as
compared with the respective controls BG controls. exoMix-BG de-
creased the expression of ICAM-1 in MM6-HG (Fig. 5C) and in HUVEC-
HG (Fig. 5E) as compared with their respective HG controls. The ex-
pression of ICAM-1 in MM6-BG and HUVEC-BG exposed to exoMix BG
was increased as compared with the respective BG controls (Fig. 5D and
F). The expression of ICAM-1 in MM6-HG and HUVEC-HG exposed with
exoMix-HG was not diﬀerent as compared with ICAM-1 expression in
the respective HG controls (Fig. 5D and F).
4. Discussion
DMT2 is associated with monocyte and endothelial cell activation.
One of the factors responsible for endothelial cell and monocyte acti-
vation is hyperglycemia (Davison et al., 2017; Manduteanu et al.,
1999). In the present study, we evaluated whether monocytes and en-
dothelial cells were activated by high glucose. This was measured by
measuring the expression of ICAM-1, which is a well-known activation
marker for both cell types. We also studied whether this eﬀect was
mediated by exosomes. Secondly, we evaluated whether endothelial
cells and monocytes communicate with each other via exosomes under
basal and high glucose conditions.
In the present study, we conﬁrm production of exosomes induced by
HG in endothelial cells, but to the best of our knowledge, this is the ﬁrst
study showing changes in exosomes produced by monocytes under the
inﬂuence of HG. Rather than isolating monocytes from blood, which
isolation procedure activates monocytes (Faas et al., 2010), we used the
MM6 cell line as a model for monocytes because of its low basal acti-
vation. This cell line shows many characteristics of mature monocytes
(Ziegler‐Heitbroc et al., 1988). We showed that the exposure to HG
modiﬁed the size of exosomes from MM6 but did not signiﬁcantly alter
the concentration of exosomes. This was diﬀerent from the eﬀect of HG
on HUVEC that we described previously (Sáez et al., 2018), in which we
observed that HG increased the concentration of exosomes but not the
size. Moreover, our results suggest that HG can probably also alter the
content of the exosomes derived from both monocytes, since exosomes
isolated from monocytes incubated in HG have diﬀerent eﬀects on
monocyte ICAM-1 surface expression as compared with exosomes iso-
lated from monocytes incubated in BG.
HG increased the expression of ICAM-1 in MM6 cells. Our results are
in line with a study by Shanmugan et al. (Shanmugam et al., 2003),
who showed that incubation of monocytes with high glucose activated
monocytes. In this study monocyte activation was characterized by
increased production of inﬂammatory cytokines such as TNF-α and
MCP-1 (Shanmugam et al., 2003). In line with our previous study (Sáez
et al., 2018), HG also increased endothelial cell activation, which is also
in line with other studies (Takami et al., 1998). The cellular mechan-
isms by which HG induced monocyte and endothelial cell activation
cannot be deduced from our study. However, previous studies have
shown that HG induces the production of oxygen free radicals (Dasu
and Jialal, 2011; Li et al., 2016). It seems likely that such oxygen free
radicals induce monocyte and endothelial cell activation (Chiu et al.,
1997; Kim et al., 2011).
We speculated that the eﬀect of HG on monocytes (and endothelial
cells as previously described) was induced by exosomes. Therefore
MM6-BG cells were exposed to exoMM6-HG. This indeed caused in-
creased ICAM-1 cell surface protein expression, suggesting that the ef-
fect of HG can indeed be induced by exosomes derived from cells in-
cubated under HG. The exposure of MM6-HG to exoMM6-BG or
exoMM6-HG, as well as the exposure of MM6-BG to exoMM6-BG, also
increased the expression of ICAM-1. This may suggest that the eﬀect of
exosomes on ICAM-1 expression is an exosomal eﬀect and not speciﬁc
for exosomes derived from monocytes under HG condition.
In vivo, monocytes and endothelial cells are in close contact. Thus,
we evaluated whether monocytes and endothelial cells are able to
communicate with each other under basal and high glucose conditions
via exosomes. The exposure of MM6-BG to exoHUVEC-HG or
exoHUVEC-BG signiﬁcantly increased the expression of ICAM-1 in these
cells. Again, this may suggest that exosomes per se activate monocytes,
i.e. increased their ICAM-1 expression, independent of the glucose
concentration. Further studies are needed to evaluate whether (and
how) exosomes from HUVECs may also inﬂuence MM6 in other ways,
f.i by inducing cytokine expression. Interestingly, the exposure of
HUVEC-BG to exoMM6-HG increased the expression of ICAM-1 as
compared with HUVEC-BG and HUVEC-HG. Remarkably, exoMM6-BG
incubated with HUVEC-HG reversed the eﬀect of HG to almost normal
values.
Our data of monocyte exosomes aﬀecting endothelial cells are in
line with the study of Tang et al. (Tang et al., 2016), who observed that
Fig. 4. Eﬀect of exosomes derived from MM6 on HUVECs ICAM-1 expression. A: Percentage of positive cells for ICAM-1 was evaluated in HUVECs exposed to BG and
to HG (HUVEC-BG and HUVEC-HG, respectively) and compared with percentage of positive cells for ICAM-1 in HUVEC-BG and HG cells exposed exosomes from
MM6-HG (exoMM6-HG) and/or MM6-BG (exoMM6-BG). B: The Percentage of positive cells for ICAM-1 was evaluated in MM6 cells exposed to BG and HG and
compared to percentage of positive cells for ICAM-1 in MM6-BG and HG cells exposed exosomes from HUVEC-HG (exoHUVEC-HG) and from HUVEC-BG (exoHUVEC-
BG) (n=5 in all conditions). p < 0.05, Wilcoxon signed rank test (* vs MM6-BG, + vs MM6-HG).
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exosomes derived from LPS-activated monocytes induced the expres-
sion ICAM-1 and pro-inﬂammatory cytokines in HUVECs. Not only
exosomes, but also microparticles derived from leukocytes stimulate the
expression of ICAM-1 on endothelial cells (Mesri and Altieri, 1998).
Although, we did not investigate the mechanisms by which monocyte
exosomes aﬀect endothelial cells, other studies have shown that
monocyte exosomes aﬀected endothelial cells by activating NFκB and
Toll like receptor signaling pathways (Bretz et al., 2013; Tang et al.,
Fig. 5. Eﬀect of a mix of exosomes derived from monocytes and endothelial cells on ICAM-1 expression in MM6 cells and HUVECs, under BG and HG condition. A)
Percentage of positive cells for ICAM-1 was evaluated in MM6 cells and in HUVECs in co-cultures under BG or HG conditions. B) Percentage of positive cells for ICAM-
1 was evaluated in MM6 cells and in HUVECs in monocultures under BG or HG conditions. C–D) Percentage of positive cells for ICAM-1 was evaluated in MM6-BG
and in MM6-HG exposed to exosomes from MM6-HUVEC-BG or MM6-HUVEC-HG (exoMix-BG or exoMix-HG), respectively. E–F) Percentage of positive cells for
ICAM-1 was evaluated in HUVEC-BG and in HUVEC-HG exposed to exosomes from MM6-HUVEC-BG or MM6-HUVEC-HG (exoMix-BG or exoMix-HG), respectively.
(n=5 in all conditions). p < 0.05, Wilcoxon Signed rank test (a vs MM6-BG or HUVEC-BG, * vs MM6-BG or HUVEC-BG, + vs MM6-HG or HUVEC-HG, ! vs exoMix-
HG).
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2016). However, whether the increased ICAM-1 expression mediated by
exosomes may aﬀect the interaction between endothelial cells and
monocytes, i.e. monocytes transmigration, was not evaluated in this
study. Together, these data suggest that in vivo, exosomes derived from
both cells types may be one of the mechanisms inducing endothelial cell
and monocyte activation under hyperglycemic conditions.
In view of the eﬀects of exosomes from MM6 and HUVECs on each
other, we hypothesized that in a co-culture of MM6 and HUVECs, under
HG or BG conditions, ICAM-1 expression would be increased as com-
pared with monocultures of either HUVECs of MM6. This hypothesis
appeared to be true: co-cultured HUVECs and MM6 showed higher
ICAM-1 expression as compared with monocultures, however, only
under high glucose conditions. We also observed that, similar to
monocultures, both HUVECs and MM6 cells exposed to HG in co-culture
increased the expression of ICAM-1 as compared to co-cultured cells
exposed to BG. In line with the present data, we have previously shown
communication between monocytes and endothelial cells (Faas et al.,
2010). We hypothesized that in co-culture MM6 and HUVECs com-
municate by exosome production. Alternatively, but not mutually ex-
clusive, HG may also cause increased release of pro-inﬂammatory cy-
tokines by monocytes (Li-bo et al., 2011) or endothelial cells (Liu et al.,
2012), by which these cells may also activate each other (Altannavch
et al., 2004; Manna and Jain, 2014).
In accordance with our hypothesis, the exosomal mixture of
HUVECs and MM6 exosomes from cells incubated under high glucose
increased the expression of ICAM-1 in both HUVECs and MM6 cultured
under basal glucose. Interestingly, ICAM-1 levels were increased to the
same level as ICAM-1 in co-cultured MM6 cells, i.e. higher than in
monocultures. This may suggest that the exosomes from HUVECs and
MM6 under high glucose collaborate in inducing ICAM-1 protein sur-
face expression in both HUVECs and MM6. These data thus conﬁrm our
hypothesis that in co-cultured HUVECs and MM6 cells exosomes from
both cell types collaborate and that exosomes are, at least partly, re-
sponsible for increasing ICAM-1 expression in both cell types.
Moreover, we observed that the exosomal mix from HUVECs and MM6
under BG decreased the expression of ICAM-1 in both HUVECs and
MM6 incubated with HG, i.e. they reverted the eﬀect of high glucose on
both HUVECs and MM6. Further studies are needed to investigate the
exact mechanisms of how the exosomes inﬂuence ICAM-1 expression
and how MM6 and HUVECs exosomes collaborate.
In summary, our results indicate that high levels of glucose may
activate monocytes. The present data also show that exosomes derived
from both monocytes and endothelial cells can modulate the protein
surface expression of ICAM-1 in endothelial cells and in monocytes.
Exosomes can thus act as communication mechanism between mono-
cytes and endothelial cells, both under BG and HG conditions. Despite,
this study did not show whether exosomes derived from monocytes and
endothelial cells may aﬀect exosome cargo, this eﬀect of HG could be in
line with data showing that circulating microparticles from DMT2 pa-
tients are enriched with proteins involved in cell activation (Xu et al.,
2016). Also exosomes derived from myocytes from patients with DMT2
contain higher levels of microRNA-1 and microRNA-133a, as compared
with exosomes from healthy individuals (de Gonzalo-Calvo et al.,
2017). Studies into the cargo of HG and BG exosomes are in progress.
We propose that exosomes from both endothelial cells and monocytes
have an important role endothelial and monocyte activation induced by
high levels of glucose and may play a role in inﬂammatory cell acti-
vation in DMT2 (Fig. 6) or cardiovascular complications associated
with diabetes.
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